Latest News
Oct. 2008
AFP, PIVKA II, GP3, SCCA-I and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease.
- For more information, please visit this page "HCC Biomarkers"
Meetings
DDW 2009
Digestive Disease Week
May 30th - June 4th 2009, Chicago
AACC 2009
American Association of Clinical Chemistry
July 21-23 2009, Chicago
CAP 2009
The Pathologists Meeting
October 11-14, DC
TLM 2009
The Liver Meeting
October 30-Nov 3, Boston
Contact Us
Email: Clinical Diagnostic Reagents
Email: AFP-L3%, DCP and LiBASys
Email: APOLOWAKO
Wako is a comprehensive manufacturer of Clinical Diagnostic reagents that are of the highest quality and extremely cost competitive. Our products are the result of over 75 years of dedication to the field of in vitro diagnostics.
General Info
Product List
Product Detail
AFP-L3% and DCP (also known as PIVKA-II) are available through major reference labs. DCP and AFP-L3% have received 510(k) clearance approvals from the FDA as risk assessment tests for the development of HCC.
For Doctors
- HCC Biomarkers
- DCP (PIVKA-II) Test
- AFP-L3% Test
- Improved HCC Surveillance
- Ordering Test
- News Archive
- Reference Library
For Lab Directors
For Patients
APOLOWAKO is a CLIA waived fully-integrated bench top clinical chemistry analyzer designed for use in a Point-of-Care setting.